Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial

Details

Database :

OAIster

Journal :

The Lancet Oncology

Publication Type :

Electronic Resource

Accession number :

edsoai.on1076892729

Document Type :

Electronic Resource